Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nataliya V Uboha"'
Publikováno v:
Journal of Clinical Oncology. 40:2751-2762
Immunotherapy (IO) agents have led to significant improvements in patient outcomes across many tumor types. There have been great efforts to introduce immune checkpoint inhibitors into the treatment paradigm of esophagogastric cancers as well. A numb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34760a2f4458c47ef726dcae06aea99c
https://doi.org/10.1200/jco.21.02500
https://doi.org/10.1200/jco.21.02500
Autor:
Manish A. Shah, Erin B. Kennedy, Ashley E. Alarcon-Rozas, Thierry Alcindor, Angela N. Bartley, Aubrey Belk Malowany, Nishin A. Bhadkamkar, Dana C. Deighton, Yelena Janjigian, Asha Karippot, Uqba Khan, Daniel A. King, Kelsey Klute, Jill Lacy, James J. Lee, Rutika Mehta, Sarbajit Mukherjee, Arun Nagarajan, Haeseong Park, Anwaar Saeed, Thomas J. Semrad, Kohei Shitara, Elizabeth Smyth, Nataliya V. Uboha, Melani Vincelli, Zev Wainberg, Lakshmi Rajdev
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
PURPOSE To develop recommendations involving targeted therapies for patients with advanced gastroesophageal cancer. METHODS The American Society of Clinical Oncology convened an Expert Panel to conduct a systematic review of relevant studies and deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6ff95cf0ea6cda10c66173c65a6df5
https://pubmed.ncbi.nlm.nih.gov/36603169
https://pubmed.ncbi.nlm.nih.gov/36603169
Autor:
Ruiqi Geng, Yuxin Zhang, James Rice, Matthias R. Muehler, Jitka Starekova, David R. Rutkowski, Nataliya V. Uboha, Ali Pirasteh, Alejandro Roldán‐Alzate, Arnaud Guidon, Diego Hernando
Publikováno v:
Magnetic resonance in medicine. 89(3)
To evaluate feasibility and reproducibility of liver diffusion-weighted (DW) MRI using cardiac-motion-robust, blood-suppressed, reduced-distortion techniques.DW-MRI data were acquired at 3T in an anatomically accurate liver phantom including controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e082005db9c9febed3b32691a40118a
https://pubmed.ncbi.nlm.nih.gov/36404637
https://pubmed.ncbi.nlm.nih.gov/36404637
Autor:
Elena Garralda Cabanas, Elisa Fontana, Honey Kumar Oberoi, Nataliya V. Uboha, Ecaterina E. Dumbrava, Emiliano Calvo, Giuseppe Curigliano, Diwakar Davar, Bridget K. Keenan, Vincent K. Lam, Sudhir Manda, Amitkuma Mehta, Anna Minchom, Alison Moskowitz, Ravi Paluri, Vincent Ribrag, Donald Richards, Lillian Siu, Paul Swiecicki, Trisha Wise-Draper, Jasmine Zain, Andres Forero-Torres, Ping Xu, Stephen Ansell
Publikováno v:
Cancer Research. 83:CT265-CT265
Background: T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) is an inhibitory immune checkpoint receptor expressed on subsets of T-cells and natural killer (NK) cells. TIGIT inhibits T and NK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b3b700f4a3c6686232bf48d3c27daca
https://doi.org/10.1158/1538-7445.am2023-ct265
https://doi.org/10.1158/1538-7445.am2023-ct265
Autor:
Jonathan D Schoenfeld, Anita Giobbie-Hurder, Srinika Ranasinghe, Katrina Z Kao, Ana Lako, Junko Tsuji, Yang Liu, Ryan C Brennick, Ryan D Gentzler, Carrie Lee, Joleen Hubbard, Susanne M Arnold, James L Abbruzzese, Salma K Jabbour, Nataliya V Uboha, Kevin L Stephans, Jennifer M Johnson, Haeseong Park, Liza C Villaruz, Elad Sharon, Howard Streicher, Mansoor M Ahmed, Hayley Lyon, Carrie Cibuskis, Niall Lennon, Aashna Jhaveri, Lin Yang, Jennifer Altreuter, Lauren Gunasti, Jason L Weirather, Raymond H Mak, Mark M Awad, Scott J Rodig, Helen X Chen, Catherine J Wu, Arta M Monjazeb, F Stephen Hodi
Publikováno v:
Lancet Oncol
The Lancet. Oncology, vol 23, iss 2
The Lancet. Oncology, vol 23, iss 2
BackgroundPatients with non-small-cell lung cancer (NSCLC) that is resistant to PD-1 and PD-L1 (PD[L]-1)-targeted therapy have poor outcomes. Studies suggest that radiotherapy could enhance antitumour immunity. Therefore, we investigated the potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb413a3e2f50d891f3a6467eb8df660
https://pubmed.ncbi.nlm.nih.gov/35358457
https://pubmed.ncbi.nlm.nih.gov/35358457
Autor:
Nataliya V, Uboha, Sam J, Lubner, Noelle K, LoConte, Daniel L, Mulkerin, Jens C, Eickhoff, Dustin A, Deming
Publikováno v:
Investigational new drugs. 38(5)
Neuroendocrine tumors (NETs) are understudied and have limited systemic treatment options. Prior studies for patients with advanced NETs have demonstrated promising results when antimetabolite agents, including fluoropyrimidines, were combined with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d296cf0fe016827f8da0598c60eaa4d5
https://pubmed.ncbi.nlm.nih.gov/32253554
https://pubmed.ncbi.nlm.nih.gov/32253554